» Articles » PMID: 20007140

Interleukin-3 Promotes Hemangioblast Development in Mouse Aorta-gonad-mesonephros Region

Overview
Journal Haematologica
Specialty Hematology
Date 2009 Dec 17
PMID 20007140
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The hemangioblast is a bi-potential precursor cell with the capacity to differentiate into hematopoietic and vascular cells. In mouse E7.0-7.5 embryos, the hemangioblast can be identified by a clonal blast colony-forming cell (BL-CFC) assay or single cell OP9 co-culture. However, the ontogeny of the hemangioblast in mid-gestation embryos is poorly defined.

Design And Methods: The BL-CFC assay and the OP9 system were combined to illustrate the hemangioblast with lymphomyeloid and vascular potential in the mouse aorta-gonad-mesonephros region. The colony-forming assay, reverse transcriptase polymerase chain reaction analysis, immunostaining and flow cytometry were used to identify the hematopoietic potential, and Matrigel- or OP9-based methods were employed to evaluate endothelial progenitor activity.

Results: Functionally, the aorta-gonad-mesonephros-derived BL-CFC produced erythroid/myeloid progenitors, CD19(+) B lymphocytes, and CD3(+)TCRbeta(+) T lymphocytes. Meanwhile, the BL-CFC-derived adherent cells generated CD31(+) tube-like structures on OP9 stromal cells, validating the endothelial progenitor potential. The aorta-gonad-mesonephros-derived hemangioblast was greatly enriched in CD31(+), endomucin(+) and CD105(+) subpopulations, which collectively pinpoints the endothelial layer as the main location. Interestingly, the BL-CFC was not detected in yolk sac, placenta, fetal liver or embryonic circulation. Screening of candidate cytokines revealed that interleukin-3 was remarkable in expanding the BL-CFC in a dose-dependent manner through the JAK2/STAT5 and MAPK/ERK pathways. Neutralizing interleukin-3 in the aorta-gonad-mesonephros region resulted in reduced numbers of BL-CFC, indicating the physiological requirement for this cytokine. Both hematopoietic and endothelial differentiation potential were significantly increased in interleukin-3-treated BL-CFC, suggesting a persistent positive influence. Intriguingly, interleukin-3 markedly amplified primitive erythroid and macrophage precursors in E7.5 embryos. Quantitative polymerase chain reaction analysis demonstrated declined Flk-1 and elevated Scl and von Willebrand factor transcription upon interleukin-3 stimulation, indicating accelerated hemangiopoiesis.

Conclusions: The hemangioblast with lymphomyeloid potential is one of the precursors of definitive hematopoiesis in the mouse aorta-gonad-mesonephros region. Interleukin-3 has a regulatory role with regards to both the number and capacity of the dual-potential hemangioblast.

Citing Articles

Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions.

Lyadova I, Gerasimova T, Nenasheva T Front Cell Dev Biol. 2021; 9:640703.

PMID: 34150747 PMC: 8207294. DOI: 10.3389/fcell.2021.640703.


A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification.

Ackermann M, Haake K, Kempf H, Kaschutnig P, Weiss A, Nguyen A Haematologica. 2020; 106(5):1354-1367.

PMID: 32327499 PMC: 8094103. DOI: 10.3324/haematol.2019.228064.


ATF4 plays a pivotal role in the development of functional hematopoietic stem cells in mouse fetal liver.

Zhao Y, Zhou J, Liu D, Dong F, Cheng H, Wang W Blood. 2015; 126(21):2383-91.

PMID: 26384355 PMC: 4653766. DOI: 10.1182/blood-2015-03-633354.


The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers.

Baxter E, Mirabella F, Bowers S, James S, Bonavita A, Bertrand E J Immunol. 2012; 189(9):4459-69.

PMID: 23024272 PMC: 3480713. DOI: 10.4049/jimmunol.1201915.


Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.

Choi K, Vodyanik M, Togarrati P, Suknuntha K, Kumar A, Samarjeet F Cell Rep. 2012; 2(3):553-67.

PMID: 22981233 PMC: 3462245. DOI: 10.1016/j.celrep.2012.08.002.


References
1.
Lacaud G, Kouskoff V, Trumble A, Schwantz S, Keller G . Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells. Blood. 2003; 103(3):886-9. DOI: 10.1182/blood-2003-06-2149. View

2.
Gekas C, Dieterlen-Lievre F, Orkin S, Mikkola H . The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005; 8(3):365-75. DOI: 10.1016/j.devcel.2004.12.016. View

3.
Ferkowicz M, Yoder M . Blood island formation: longstanding observations and modern interpretations. Exp Hematol. 2005; 33(9):1041-7. DOI: 10.1016/j.exphem.2005.06.006. View

4.
Murry C, Keller G . Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008; 132(4):661-80. DOI: 10.1016/j.cell.2008.02.008. View

5.
Ottersbach K, Dzierzak E . The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell. 2005; 8(3):377-87. DOI: 10.1016/j.devcel.2005.02.001. View